Kimberly J Reidy1, Rebecca Hjorten1,2, Rulan S Parekh3. 1. Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York. 2. Department of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. 3. Departments of Pediatrics and Medicine, Hospital for Sick Children, University Health Network and University of Toronto, Toronto, Ontario, Canada.
Abstract
PURPOSE OF REVIEW: Understanding the genetic risk of APOL1 in children and young adults is important given the lifetime risk of hypertension and kidney disease among children of African descent. We review recent epidemiologic and biologic findings on the effects of APOL1 and kidney disease. RECENT FINDINGS: APOL1 in children and young adults is associated with hypertension, albuminuria and more rapid decline in kidney function and progression to end-stage kidney disease, especially among those with glomerular causes of kidney disease, and those affected by sickle cell disease or HIV. There are conflicting data on the APOL1 association with cardiovascular disease in children and young adults. APOL1 functions as part of the innate immune system. Podocyte expression of APOL1 likely contributes to the development of kidney disease. In cell culture and model organisms, APOL1 expression disrupts autophagic and ion flux, leads to defects in mitochondrial respiration and induces cell death. SUMMARY: APOL1 explains almost 70% of the excess risk of kidney disease in those of African descent, and is common in children with glomerular disease. An evolving understanding of the pathogenesis of APOL1-mediated kidney damage may aid in personalized medicine approaches to APOL1 attributable kidney disease.
PURPOSE OF REVIEW: Understanding the genetic risk of APOL1 in children and young adults is important given the lifetime risk of hypertension and kidney disease among children of African descent. We review recent epidemiologic and biologic findings on the effects of APOL1 and kidney disease. RECENT FINDINGS:APOL1 in children and young adults is associated with hypertension, albuminuria and more rapid decline in kidney function and progression to end-stage kidney disease, especially among those with glomerular causes of kidney disease, and those affected by sickle cell disease or HIV. There are conflicting data on the APOL1 association with cardiovascular disease in children and young adults. APOL1 functions as part of the innate immune system. Podocyte expression of APOL1 likely contributes to the development of kidney disease. In cell culture and model organisms, APOL1 expression disrupts autophagic and ion flux, leads to defects in mitochondrial respiration and induces cell death. SUMMARY:APOL1 explains almost 70% of the excess risk of kidney disease in those of African descent, and is common in children with glomerular disease. An evolving understanding of the pathogenesis of APOL1-mediated kidney damage may aid in personalized medicine approaches to APOL1 attributable kidney disease.
Authors: Pazit Beckerman; Jing Bi-Karchin; Ae Seo Deok Park; Chengxiang Qiu; Patrick D Dummer; Irfana Soomro; Carine M Boustany-Kari; Steven S Pullen; Jeffrey H Miner; Chien-An A Hu; Tibor Rohacs; Kazunori Inoue; Shuta Ishibe; Moin A Saleem; Matthew B Palmer; Ana Maria Cuervo; Jeffrey B Kopp; Katalin Susztak Journal: Nat Med Date: 2017-02-20 Impact factor: 53.440
Authors: Amy Geard; Gift D Pule; Bernard Chetcha Chemegni; Valentina J Ngo Bitoungui; Andre P Kengne; Emile R Chimusa; Ambroise Wonkam Journal: Br J Haematol Date: 2017-05-03 Impact factor: 6.998
Authors: B T Lee; V Kumar; T A Williams; R Abdi; A Bernhardy; C Dyer; S Conte; G Genovese; M D Ross; D J Friedman; R Gaston; E Milford; M R Pollak; A Chandraker Journal: Am J Transplant Date: 2012-04-04 Impact factor: 8.086
Authors: Leslie A Bruggeman; Zhenzhen Wu; Liping Luo; Sethu M Madhavan; Martha Konieczkowski; Paul E Drawz; David B Thomas; Laura Barisoni; John R Sedor; John F O'Toole Journal: J Am Soc Nephrol Date: 2016-03-29 Impact factor: 10.121
Authors: Murli U Purswani; Kunjal Patel; Cheryl A Winkler; Stephen A Spector; Rohan Hazra; George R Seage; Lynne Mofenson; Brad Karalius; Gwendolyn B Scott; Russell B Van Dyke; Jeffrey B Kopp Journal: J Acquir Immune Defic Syndr Date: 2016-09-01 Impact factor: 3.731
Authors: Robert P Woroniecki; Derek K Ng; Sophie Limou; Cheryl A Winkler; Kimberly J Reidy; Mark Mitsnefes; Matthew G Sampson; Craig S Wong; Bradley A Warady; Susan L Furth; Jeffrey B Kopp; Frederick J Kaskel Journal: Front Pediatr Date: 2016-11-17 Impact factor: 3.418
Authors: Anneli Cooper; Hamidou Ilboudo; V Pius Alibu; Sophie Ravel; John Enyaru; William Weir; Harry Noyes; Paul Capewell; Mamadou Camara; Jacqueline Milet; Vincent Jamonneau; Oumou Camara; Enock Matovu; Bruno Bucheton; Annette MacLeod Journal: Elife Date: 2017-05-24 Impact factor: 8.140
Authors: Jayme E Locke; Deirdre Sawinski; Rhiannon D Reed; Brittany Shelton; Paul A MacLennan; Vineeta Kumar; Shikha Mehta; Roslyn B Mannon; Robert Gaston; Bruce A Julian; John J Carr; James G Terry; Meredith Kilgore; Allan B Massie; Dorry L Segev; Cora E Lewis Journal: Ann Surg Date: 2018-06 Impact factor: 13.787
Authors: Jill R Krissberg; Margaret E Helmuth; Salem Almaani; Yi Cai; Daniel Cattran; Debanjana Chatterjee; Rasheed A Gbadegesin; Keisha L Gibson; Dorey A Glenn; Laurence A Greenbaum; Sandra Iragorri; Koyal Jain; Myda Khalid; Jason M Kidd; Jeffrey B Kopp; Richard Lafayette; Jordan G Nestor; Rulan S Parekh; Kimberly J Reidy; C John Sperati; Katherine R Tuttle; Katherine Twombley; Tetyana L Vasylyeva; Donald Jack Weaver; Scott E Wenderfer; Michelle M O'Shaughnessy Journal: Glomerular Dis Date: 2021-06-24
Authors: Pepe M Ekulu; Agathe B Nkoy; Oyindamola C Adebayo; Orly K Kazadi; Michel N Aloni; Fanny O Arcolino; Rene M Ngiyulu; Jean-Lambert E Gini; François B Lepira; Lamberthus P Van den Heuvel; Elena N Levtchenko Journal: Pediatr Nephrol Date: 2020-04-06 Impact factor: 3.714
Authors: Barry I Freedman; Wylie Burke; Jasmin Divers; Lucy Eberhard; Crystal A Gadegbeku; Rasheed Gbadegesin; Michael E Hall; Tiffany Jones-Smith; Richard Knight; Jeffrey B Kopp; Csaba P Kovesdy; Keith C Norris; Opeyemi A Olabisi; Glenda V Roberts; John R Sedor; Erika Blacksher Journal: J Am Soc Nephrol Date: 2021-04-14 Impact factor: 14.978
Authors: Xiumei Hong; Avi Z Rosenberg; Boyang Zhang; Elizabeth Binns-Roemer; Victor David; Yiming Lv; Rebecca C Hjorten; Kimberly J Reidy; Teresa K Chen; Guoying Wang; Yuelong Ji; Claire L Simpson; Robert L Davis; Jeffrey B Kopp; Xiaobin Wang; Cheryl A Winkler Journal: Am J Kidney Dis Date: 2020-12-22 Impact factor: 11.072
Authors: Anna R Kahkoska; Teeranan Pokaprakarn; G Rumay Alexander; Tessa L Crume; Dana Dabelea; Jasmin Divers; Lawrence M Dolan; Elizabeth T Jensen; Jean M Lawrence; Santica Marcovina; Amy K Mottl; Catherine Pihoker; Sharon H Saydah; Michael R Kosorok; Elizabeth J Mayer-Davis Journal: Diabetes Care Date: 2022-01-01 Impact factor: 17.152
Authors: Pepe M Ekulu; Agathe B Nkoy; Dieumerci K Betukumesu; Michel N Aloni; Jean Robert R Makulo; Ernest K Sumaili; Eric M Mafuta; Mohamed A Elmonem; Fanny O Arcolino; Faustin N Kitetele; François B Lepira; Lambertus P van den Heuvel; Elena N Levtchenko Journal: Kidney Int Rep Date: 2019-04-11